José María Ruiz Moreno-rekin lankidetzan egindako argitalpenak (8)

2015

  1. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: The Retina 4 project

    Acta Ophthalmologica, Vol. 93, Núm. 7, pp. e541-e549

  2. Predicting proliferative vitreoretinopathy: Temporal and external validation of models based on genetic and clinical variables

    British Journal of Ophthalmology, Vol. 99, Núm. 1, pp. 41-48

2013

  1. A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 3, pp. 1665-1678

  2. External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: The retina 1 project; Report 5

    Retina, Vol. 33, Núm. 8, pp. 1519-1527

  3. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy

    PLoS ONE, Vol. 8, Núm. 12

  4. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: The retina 4 project

    Ophthalmology, Vol. 120, Núm. 3, pp. 623-628

2010

  1. A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: The Retina 4 Project

    Ophthalmology, Vol. 117, Núm. 12

2008

  1. Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: The Retina 1 Project - Report 2

    British Journal of Ophthalmology, Vol. 92, Núm. 3, pp. 378-382